U.S CDC investigates harmful reactions to counterfeit Botox injections
America
By
Xinhua
| Apr 16, 2024
The U.S Centers for Disease Control and Prevention (CDC) is investigating reports of harmful reactions among people who received injections of counterfeit or mishandled botulinum toxin, known as "Botox," the agency said on Monday.
As of Monday, the CDC has received reports of 19 people in nine states who experienced harmful reactions after receiving counterfeit Botox injections or injections administered by unlicensed or untrained individuals and (or) in non-healthcare settings, such as homes or spas.
Nine people have been hospitalized and four were treated with botulism antitoxin because symptoms were consistent with the possible spread of toxin, according to the CDC. No deaths have been reported.
Many of the products being investigated are counterfeit or were administered in non-healthcare settings, such as homes and spas, or by an unlicensed or untrained individual, according to the CDC.
The CDC is working with several state and local health departments. Moreover, the U.S. Food and Drug Administration (FDA) has intervened in the investigation.
READ MORE
Government clarifies labor agreement with Germany, dismisses claims of 250,000 jobs
Battle royale as Kipyegon leads chase for glory in Brussels continues this even
Bullish Harambee Stars coach says he is ready for Cameroon
Avire stars as impressive Harambee stun Brave Warriors in Afcon qualifiers
AFCON 2025 qualifiers: Harambee Stars tame Namibia to top Group J
Harambee Stars face Namibia in must-win AFCON 2025 qualifier from 7pm
Why Firat's blame game won't take Kenya back to Afcon finals next year
Firat's tactics under scrutiny as Harambee Stars seek redemption against Namibia
AFCON 2025: Poor Harambee Stars drop points against Zimbabwe
Olunga doubtful as Firat's Harambee Stars prepare for Zimbabwe test